First human tests begin for new Weight-Loss pill
NCT ID NCT06562907
Summary
This is an early-stage study to test a new oral drug called GS-4571 for weight management. Researchers will give the drug to healthy people, people with obesity, and people with type 2 diabetes to see how their bodies process it and to check for side effects. The main goal is to understand the drug's safety and how it behaves in the body before testing if it helps with weight loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WEIGHT MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON
RECRUITINGSalt Lake City, Utah, 84124, United States
-
ICON Early Phase Services, LLC
RECRUITINGSan Antonio, Texas, 78209, United States
-
Qps-Mra, Llc.
RECRUITINGMiami, Florida, 33143, United States
Conditions
Explore the condition pages connected to this study.